This is part of the work we're doing, analyzing the situation and looking at both legislative questions and resource questions.
Other countries, like the U.S., the EU, and Japan, have worked on updating their legislation in recent years. We're all responding to the same international phenomenon.
If you look at some of the developing countries with less secure systems, they have much more significant problems than we do when it comes to health and safety issues. In some of the least-developed countries, up to 50% of the pharmaceuticals sold there are fake.
It's a recognized problem in Canada that we're working on, but it's a major international problem.